Ivica Grgurevic
Overview
Explore the profile of Ivica Grgurevic including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
93
Citations
635
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Grgurevic I, Filipec Kanizaj T, Ivekovic H, Mikolasevic I, Milic S, Mrzljak A, et al.
Acta Clin Croat
. 2025 Feb;
63(1):214-243.
PMID: 39959335
Liver diseases are currently the eleventh leading cause of global mortality, and cirrhosis holds the ninth position among the causes of death in Europe. The progression of cirrhosis gives rise...
2.
Dong B, He R, Ju S, Chen Y, Grgurevic I, Ma J, et al.
Clin Mol Hepatol
. 2025 Feb;
PMID: 39905838
Background/aims: A large percentage of patients undergoing esophagogastroduodenoscopy (EGD) screening do not have esophageal varices (EV) or have only small EV. We evaluated a large, international, multicenter cohort to develop...
3.
Gu W, de Ledinghen V, Aube C, Krag A, Strassburg C, Castera L, et al.
NEJM Evid
. 2024 Oct;
3(11):EVIDoa2400062.
PMID: 39437136
Background: Patients with advanced chronic liver disease (ACLD) are at high risk of developing hepatocellular carcinoma (HCC). Therefore, biannual surveillance is recommended. This large-scale multicenter study aimed to stratify the...
4.
Bokun T, Tadic M, Kurtcehajic A, Grgurevic I, Kujundzic M
Endoscopy
. 2024 Jul;
52(12):C11.
PMID: 39030670
No abstract available.
5.
Liu C, You H, Zeng Q, Wong Y, Wang B, Grgurevic I, et al.
Clin Mol Hepatol
. 2024 Jul;
31(1):105-118.
PMID: 38988296
Backgrounds/aims: Non-invasive models stratifying clinically significant portal hypertension (CSPH) are limited. Herein, we developed a new non-invasive model for predicting CSPH in patients with compensated cirrhosis and investigated whether carvedilol...
6.
Salkic N, Jovanovic P, Barisic Jaman M, Selimovic N, Pastrovic F, Grgurevic I
Diagnostics (Basel)
. 2024 May;
14(10).
PMID: 38786278
Prediction of short-term mortality in patients with acute decompensation of liver cirrhosis could be improved. We aimed to develop and validate two machine learning (ML) models for predicting 28-day and...
7.
Barisic-Jaman M, Milosevic M, Pastrovic F, Skrtic A, Grgurevic I
Clin Exp Hepatol
. 2024 May;
9(4):297-306.
PMID: 38774199
Porto-sinusoidal vascular disease (PSVD) is defined as a vascular liver disease characterized by the absence of cirrhosis and the presence of characteristic histological features, with or without the presence of...
8.
He R, Liu C, Grgurevic I, Guo Y, Xu H, Liu J, et al.
Hepatol Int
. 2024 May;
18(3):1020-1028.
PMID: 38740698
Background: The Baveno VII consensus proposed criteria for the non-invasively diagnosis of clinically significant portal hypertension (CSPH) in patients with compensated advanced chronic liver disease (cACLD). The performance of Baveno...
9.
Madir A, Barisic Jaman M, Milosevic M, Dinjar Kujundzic P, Grgurevic I
Diagnostics (Basel)
. 2024 Apr;
14(7).
PMID: 38611656
Spleen stiffness measurement (SSM) by transient elastography (TE) has been repeatedly demonstrated as the reliable way to rule out the presence of high-risk esophageal varices (HRV). We aimed to evaluate...
10.
Pastrovic F, Novak R, Grgurevic I, Hrkac S, Salai G, Zarak M, et al.
PLoS One
. 2024 Apr;
19(4):e0301416.
PMID: 38603681
Introduction: Portal hypertension (PH) drives the progression of liver cirrhosis to decompensation and death. Hepatic venous pressure gradient (HVPG) measurement is the standard of PH quantification, and HVPG≥10 mmHg defines...